Concepts and Core Principles of Fragment-Based Drug Design
1
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Department of Drug Design and Optimization (DDOP), Campus E8.1, 66123 Saarbrücken, Germany
2
Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany
3
German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 66123 Saarbrücken, Germany
4
Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands
*
Author to whom correspondence should be addressed.
Academic Editor: Brian J. Stockman
Molecules 2019, 24(23), 4309; https://doi.org/10.3390/molecules24234309
Received: 28 October 2019 / Revised: 11 November 2019 / Accepted: 20 November 2019 / Published: 26 November 2019
(This article belongs to the Special Issue Fragment Based Drug Discovery)
In this review, a general introduction to fragment-based drug design and the underlying concepts is given. General considerations and methodologies ranging from library selection/construction over biophysical screening and evaluation methods to in-depth hit qualification and subsequent optimization strategies are discussed. These principles can be generally applied to most classes of drug targets. The examples given for fragment growing, merging, and linking strategies at the end of the review are set in the fields of enzyme-inhibitor design and macromolecule–macromolecule interaction inhibition. Building upon the foundation of fragment-based drug discovery (FBDD) and its methodologies, we also highlight a few new trends in FBDD.
View Full-Text
Keywords:
fragment-based drug design; biophysical screening; rule-of-three; ligand efficiency; fragment optimization
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Kirsch, P.; Hartman, A.M.; Hirsch, A.K.H.; Empting, M. Concepts and Core Principles of Fragment-Based Drug Design. Molecules 2019, 24, 4309. https://doi.org/10.3390/molecules24234309
AMA Style
Kirsch P, Hartman AM, Hirsch AKH, Empting M. Concepts and Core Principles of Fragment-Based Drug Design. Molecules. 2019; 24(23):4309. https://doi.org/10.3390/molecules24234309
Chicago/Turabian StyleKirsch, Philine; Hartman, Alwin M.; Hirsch, Anna K.H.; Empting, Martin. 2019. "Concepts and Core Principles of Fragment-Based Drug Design" Molecules 24, no. 23: 4309. https://doi.org/10.3390/molecules24234309
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit
